PRNewswire 11-Jan-2019 8:00 AM
LITTLE FALLS, N.J., Jan. 11, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that it has acquired Vista Research Group, LLC. ("Vista Research Group"), a company that provides a complete line of innovative water treatment, purification and management solutions for the dental industry. The total purchase price was approximately $10.5 million in cash consideration, consisting of $7 million in an upfront payment and $3.5 million in an earnout payment based on the achievement of certain performance-based targets over a two-year period. Total sales of Vista Research Group in 2018 were approximately $2.0 million.
Vista Research Group has an innovative portfolio of solutions for filtration, purification, treatment and management of dental water to reduce the risk of infections, improve patient care, enhance practice workflow, and protect dental equipment.
"We're excited that Vista Research Group is now part of Cantel. The integration of their water treatment technologies into our existing portfolio allows us to offer our customers more comprehensive infection prevention solutions that provide clean water across all touchpoints in the dental clinic," stated Jorgen Hansen, President and CEO. "This acquisition also reinforces our position as the market leader in dental water compliance."
"The addition of Vista Research Group's solutions will broaden our dental water purification portfolio and advance the development of our product line. In addition to our DentaPure™ Cartridge, it also will enable us to provide a full suite of end-to-end dental water compliance solutions to dental practices," said Gary Steinberg, President of Cantel's Dental division. "In our ongoing commitment to infection prevention and compliance, we look forward to driving the awareness of and access to the VistaPure™, VistaCool™, and VistaClear™ products so more dental practices can benefit from improved efficiency, simplified workflows, and better protection for both patients and staff."
Cantel is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For further information, visit the Cantel website at www.cantelmedical.com.
About Vista Research Group, LLC
Vista Research Group provides a complete line of innovative water processing solutions for the dental industry. From specialized filtration to waterline cleaning and backflow prevention, Vista Research Group products save practices time and money while protecting their equipment, facilities, staff and patients.
For more information, visit the Vista Research Group website at www.vistaresearchgroup.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cantel-acquires-vista-research-group-300776658.html
SOURCE Cantel Medical Corp.
Limited Time Offer:
Claim your free copy of income expert Bryan Perry's new report:
My Top Monthly Dividend Payer (8% Dividend Yield)
You'll also receive Bryan Perry's weekly e-letter, Dividend Investing Weekly, at no cost, along with other associated financial content and special offers.